Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations  by Monassier, Jean Pierre
Archives of Cardiovascular Disease (2008) 101, 491—500
Disponib le en l igne sur www.sc iencedi rec t .com
REVIEW
Reperfusion injury in acute myocardial infarction.
From bench to cath lab. Part I: Basic considerations
Lésions myocardiques de reperfusion au cours de l’infarctus
myocardique aigu. Du laboratoire au cath lab. Première partie :
données fondamentales
Jean Pierre Monassier ∗
Cardiology Department, Emile Muller Hospital, 20, Laennec Street, 68000 Mulhouse, France
Received 11 February 2008; received in revised form 26 May 2008; accepted 6 June 2008
Available online 20 September 2008
KEYWORDS
Reperfusion injury;
Acute myocardial
infarction;
Reperfusion injury
salvage kinase
pathway
Summary Early reperfusion during evolving myocardial infarction is essential for saving
myocardium and patients’ lives. Nevertheless, lethal reperfusion injury can occur, limiting
myocardial salvage. Numerous experimental studies have proved the deleterious effects of
reoxygenating endothelial cells and cardiomyocytes. The major breakthrough was the proof
that the success of myocardial reperfusion can be modiﬁed by preconditioning and, more
recently, by postconditioning, a form of progressive and interrupted reperfusion. Three the-
ories have been put forward to explain reperfusion injury: (1) oxidative stress resulting in a
burst of oxygen-radical formation, which can cause membrane damage; (2) the energy paradox,
which suggests that restarting energetic mitochondrial machinery results in myoﬁbrillar hyper-
contracture, cytoskeleton fragility and membrane rupture; and (3) the role of inﬂammation,
which addresses the effects of leucocyte accumulation and activation. Fortunately, reperfusion
injury salvage kinases can be up-regulated and in some circumstances may block, in a manner
similar to pre- or postconditioning, the diabolical cycle leading to necrosis and/or apoptosis
of viable cells. The end effectors of the survival system are two mitochondrial channels — the
mK-ATP channel and the mitochondrial permeability transition pore. Better understanding of
these salutary molecular mechanisms and their triggers may result in a new era of reperfusion
techniques.
© 2008 Elsevier Masson SAS. All rights reserved.
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MOTS CLÉS
Lésions de
reperfusion ;
Infarctus
myocardique aigu ;
Voies de sauvetage
myocardique
dépendants et les pores de transition mitochondriaux. La connaissance de ces mécanismes
salutaires et de leurs initiateurs permet d’ouvrir une nouvelle ère de la reperfusion en phase
aiguë d’infarctus myocardique.
© 2008 Elsevier Masson SAS. All rights reserved.
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sackground
cute coronary thrombosis results in acute myocardial
nfarction with ST-segment elevation except when collat-
ral ﬂow is rapidly available. The prerequisite for saving
yocardium and patients’ lives is to restore coronary blood
ow as early as possible using thrombolytic therapy and/or
ngioplasty [1,2]. Nevertheless, interventional cardiologists
nd clinicians have reported many paradoxical features,
nown as ‘‘myocardial reperfusion syndrome’’ [3] and ‘‘no-
eﬂow’’ phenomenon [4], which occur immediately after
elief of the epicardial lesion.
Speciﬁc histological aspects of canine-reperfused
yocardium, which are clearly different from permanent
schaemia, were ﬁrst noticed by Jennings et al. as early as
960 [5]. Over the past 30 years, the debate between those
n favour of and those against the theory of deleterious
ffects resulting from myocardial reperfusion has been
he source of many controversies, including the suggestion
hat reperfusion could be a double-edged sword [6] or
s only a laboratory artefact [7]. The ﬁrst proof that
odifying reperfusion conditions can reduce infarct size
as provided by Forman et al. [8] using perﬂuorochemical
uring acute percutaneous coronary intervention (PCI).
fter numerous hopeful but ultimately unsuccessful phar-
acological attempts [9], the demonstration in 2003 of
he postconditioning phenomenon [10] mimicking pre-
onditioning [11] clearly proved that abrupt reperfusion
an kill severely ischaemic but viable myocardial cells.
he positive results of the ﬁrst randomized study of
CI and postconditioning in humans [12] proved deﬁni-
ively the concept of reperfusion injury and its clinical
elevance.
The aim of this review is to combine biological data with
linical features to demonstrate that to reperfuse is neces-
p
r
o
r
tary, but that ‘‘off—on’’ reperfusion is now overcome. The
utcome of this novel reperfusion strategy may result in the
aving of 30 to 50% more myocardium [13].
eperfusion injury: deﬁnition
he widely accepted deﬁnition of reperfusion injury [14]
ncludes metabolic and structural events that occur as a
irect result of the reopening of the epicardial segment
f the infarct-related artery, and which can be reversed by
odifying reperfusion conditions. Reperfusion injury affects
iable endothelial and myocardial cells and can result in
heir death or stunning. What is accepted as the true deﬁ-
ition of reperfusion injury must be differentiated from the
ccelerated death of non-viable cells even if the mecha-
isms are identical.
new paradigm
he previous paradigm underlying much of the scepticism
bout lethal reperfusion injury was that the main mecha-
ism leading to cell death during reperfusion was energy
eﬁciency due to the length and intensity of ischaemia.
ccording to this theory, injury occurring at the time of
eperfusion is the consequence of having reached a point of
o return in cellular metabolism. The ﬁnal size of the infarct
as regarded only as the consequence of the delay between
udden artery occlusion and reopening. Discovery of theJ.P. Monassier
Résumé La reperfusion myocardique précoce est un prérequis pour sauver du myocarde et
des vies à la phase aiguë de l’infarctus du myocarde. Néanmoins, le prix à payer est la survenue
de lésions léthales, endothéliales et cardiomyocytaires, de reperfusion aboutissant à limiter
le bénéﬁce de la reperfusion. De nombreux travaux expérimentaux ont désormais démontré la
réalité de telles lésions. Le progrès majeur a été apporté par la démonstration du précondition-
nement et du postconditionnement (une forme de reperfusion progressive et interrompue avant
une reperfusion durable). Trois théories se partagent la responsabilité des lésions de reperfu-
sion : la théorie oxydante qui donne à la synthèse explosive de radicaux libres la responsabilité
principale ; la théorie énergétique qui met sur le compte du redémarrage de la synthèse mito-
chondriale d’ATP la survenue d’hypercontracture myoﬁbrillaire qui elle-même conduit à une
fragilisation du cytosquelette et des ruptures membranaires ; enﬁn, la théorie inﬂammatoire
qui met en cause l’afﬂux et l’activation des leucocytes. Heureusement, l’existence d’une voie
de sauvetage myocardique faisant appel à une cascade de kinases a pu être démontrée et être
mise en œuvre dans certaines circonstances comme une reperfusion dont la phase d’ischémie
a été précédée d’un préconditionnement ou en cas de postconditionnemment, interrompant
le cycle infernal conduisant à la nécrose et à l’apoptose de cellules viables. Les effecteurs
ﬁnaux de ces voies de sauvetage sont des canaux mitochondriaux, les canaux potassiques ATP-henomenon of postconditioning [10], in which ‘‘staccato’’
eperfusion results in a dramatic reduction in infarct size,
pened the door to a new paradigm: the ﬁnal success of
eperfusion for myocardial ischaemia depends not only on
he ischaemic insult but also on preventable reperfusion
Reperfusion injury in acute myocardial infarction. From bench to
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mFigure 1. Ischemia and reperfusion injury (adapted from Garcia-
Dorado and Piper 2006 [13]).
injury stress (Fig. 1) [13]. While many biological and tech-
nical problems remain to be resolved, mechanically and/or
pharmacologically modiﬁed reperfusion now appears to be
a realistic goal.
Molecular basis of permanent
ischaemic-myocardium death
The two basic mechanisms of acute myocardial oxygen
deprivation are inhibition of adenosine triphosphate (ATP)
synthesis and accumulation of metabolic products due to
lack of washout. The heart is a muscle that constantly adapts
its uptake of oxygen and substrates to match its activity
level. ATP and creatine phosphate (CrP) are energy prod-
ucts, 85% of which are devoted to cardiac contraction and
the remaining 15% to membrane ion transporters and protein
synthesis [15]. During total regional myocardial ischaemia,
as is the case in ST-segment elevation myocardial infarction,
mitochondrial metabolism is depressed and ATP production
falls.
From a schematic perspective, the metabolic scenario
can be summarized as follows: the ﬁrst part, parallel to
(but not because of) reducing levels of ATP and CrP, quickly
results in reduction and arrest of cardiac contraction, which
could be considered a self-protective mechanism [15,16].
The second part is an attempt to open the salvage energy-
producing pathways. Anaerobic glycolysis, despite its low
rate of ATP production, takes over from aerobic glycolysis
and may maintain sufﬁcient energy to allow the membrane
pumps to function. Unfortunately it cannot enter the tri-
cyclic cycle and thus produces lactic acid, protons and CO2,
which in turn inhibit glycolysis. Favoured by endogenous cat-
echolamine release, lipid degradation (free fatty acids and
triglycerides) and beta oxidation start in order to produce
ATP but these processes are much more energy consuming
(oxygen wastage phenomenon) and also lead to the produc-
tion of H+. Finally, mitochondrial damage and uncoupling of
energy production stop ATP synthesis.
Then starts the third and ﬁnal episode: membrane ion
pumps stop and may even reverse (e.g. Ca2+/Na+ exchange),
leading to intracellular accumulation of H+ resulting in deep
intracellular acidosis, Na+ and Ca2+ inﬂux and a large efﬂux
i
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f K+ [19—21]. Ca2+ enters the mitochondria, provoking a
eleterious overload and inducing myoﬁbrillar permanent
ontraction (rigor contraction), even at low levels of ATP
22]. Na+ overload favours cell swelling.
Acidosis initiates lysosomal leakage, with the release of
nzymes that damage membrane phospholipids and long-
hain fatty acids. Deterioration of the cytoskeleton by
yoﬁbrillar contracture also plays a key role. All of these
vents are reversible with the exception of any damage that
as occurred to the membranes and cytoskeleton.
Historically, myocardial infarction was described by
athologists as ‘‘coagulation necrosis’’ in which cells are
ransformed into eosinophilic hyaline masses [5,23,24].
embrane (e.g. sarcolemma, sarcoplasmic reticulum, mito-
hondria) fragmentation and cell swelling are observed.
yoﬁbril contracture bands are usually considered charac-
eristic of reperfused infarctions but can also be seen in
on-reperfused tissue [13,14,22]. The progression of irre-
ersible cell damage begins in the subendocardium and
preads out towards the epicardium as a wave-front phe-
omenon [17]. The speed at which irreversibility occurs
epends on the degree of collateral ﬂow and the catecho-
ergic response [15].
Necrosis is not the only aspect associated with irre-
ersible lesions. Both necrosis and apoptosis are present
n hearts subjected to permanent total ischaemia [18].
poptotic cells (detected by immunohistochemical meth-
ds) retain their membrane integrity and do not release
ntracellular enzymes or induce acute inﬂammation. It is
rroneous to think of myocardial infarction only in terms of
ecrosis. Moreover, apoptosis may start earlier than necrosis
ecause this feature requires energy that cannot be sus-
ained at low levels of ATP.
olecular basis of lethal reperfusion injury
ethal reperfusion injury means the presence of viable
yocardial cells at the time of reﬂow. The presence of
iable myocardial cells implies that the above-mentioned
echanisms have not yet resulted in irreversible lesions, at
east in certain parts of the myocardium. One elegant exam-
le of the existence of viable cells after a long period of
schaemia is given in a study by Matsumara et al. involving
ogs [24]. The investigators used isotopic viability markers,
nd showed that at the end of the ischaemic period a large
roportion of infarcted myocardium is still viable but loses
ts viability and becomes necrotic during the ﬁrst hours of
eperfusion.
A very large volume of experimental work has been ded-
cated to the mystery surrounding reperfusion injury. It is
ossible to summarize the results, which can be classiﬁed
nto four theories, each of which has its supporters. We,
owever, propose to demonstrate that these four theories
o not conﬂict with each other.
The major initial suggestion is that reperfusion injury
ust be viewed as two different facets, one concern-ng endothelial reperfusion injury and the other myocyte
eperfusion injury. Reperfusion injury mechanisms are com-
lex and involve numerous molecular features that occur
apidly within the ﬁrst few minutes after reopening of
he vessel. Trying to describe such a complex scenario as
494 J.P. Monassier
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migure 2. Oxidative stress: origins of ROS showing the close relati
nd leukocytes. Mechanisms of the xanthine oxidase ROS synthesis
from Zweier and Talukder 2006 [27]).
learly as possible tempts us to separate artiﬁcially the
hree main harmful culprit phenomena leading to cellular
eperfusion death. They are, in fact, closely intercon-
ected.
xidative stress
xygen free radicals or reactive oxygen species (ROS) are
olecules with an odd, unpaired electron that renders the
olecule unstable and highly reactive. ROS (O2−, H2O2,
H−, NO) are normal products of endothelial and myocardial
ellular metabolism and are even triggers of many physiolog-
cal molecular reactions (e.g. cellular homeostasis, mitosis,
ifferentiation and signalling). But ischaemia-reperfusion
njury is the prototype example of a situation in which ROS
re produced in amounts far exceeding those that cells and
issues can manage without being damaged.
In 1984, Burton et al. [25] commented on the role of
OS in inducing myocardial damage. The following year,
cCord [26] claimed ‘‘It is now clear that oxygen-derived
ree radicals play an important part in several models
f experimentally induced reperfusion injury’’. Increasing
xperimental evidence has now accumulated [27], suggest-
ng that ROS are important mediators of postischaemic
eperfusion damage explaining the ‘‘oxygen paradox’’
death of reoxygenated ischaemic cells) described by Hearse
t al. [28]. Numerous techniques, including electron para-
agnetic resonance, have measured the explosive burst of
OS synthesis immediately after reperfusion but also later
27], with the ﬁrst increase occurring 15min after reper-
usion followed by a second increase between 18 and 24 h
a
e
a
b
Oip and interconnections between cardiomyocytes, endothelial cells
ay. NTP: nicotinamide transition pores; AD: adenosine deaminase
ater. The physiological antioxidative defences (e.g. cata-
ase, glutathione peroxidase and superoxide dismutase) are
verwhelmed after reperfusion [27]. ROS are formed in the
ytosol of cardiomyocytes, in endothelial cells, leukocytes
nd mitochondria [27,29], with connections between these
ifferent sites (Fig. 2). The ROS hypothesis can potentially
xplain each of the mechanisms involved in reperfusion
njury [27,29]:
inhibition of the Na+/K+ ATPase and sarcoplasmic retic-
ulum Ca2+ ATPase, both leading to cellular calcium
overload;
membrane lipid peroxidation and breakdown causing cell
swelling;
chemotaxis of neutrophils resulting in white cell plugging
of capillaries and microvascular obstruction.
In addition, white cells when activated are a potent
ource of further ROS. Cell membranes are particularly sus-
eptible to oxidation by ROS. Rearrangement of the double
onds gives rise to the formation of lipid peroxides, which in
he presence of oxygen participate in an autocatalytic chain
eaction. Generation of ROS leads to functional injury and
mpairment of contractile function.
Reactive nitrogen species have been implicated recently
n reperfusion injury [29]. NO is a well-known signalling
olecule, leading to vascular smooth muscle relax-
tion and vasodilatation, and is also implicated in the
xcitation—contraction coupling. During reperfusion, due to
disturbance of the redox state of the cells, it can be com-
ined with superoxide resulting in a very reactive radical
NOO−, the peroxynitrite. It results not only in processes
Reperfusion injury in acute myocardial infarction. From bench to
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may cease. Swelling of the mitochondrium causes a changeFigure 3. Reperfusion injury energy paradox. mPTP: mitochon-
dria permeability transition pore.
such as membrane lipid peroxidation but also in the inter-
ruption of the normal signalling pathways. NO metabolism
at reperfusion appears complex and is not fully understood.
It most likely involves dysregulation of NO synthesis due
to an alteration of the expression and localization of NO
synthases translocated from sarcoplasmic reticulum to the
sarcolemma [29]. ROS and reactive nitrogen species are
generated into the endothelium, the cardiomyocytes (mito-
chondria and cytoplasma), and by activated neutrophils.
Thus, at low concentrations, both ROS and reactive nitro-
gen species, which are closely linked, are physiological
second messengers implicated in the normal cell func-
tion. But at high levels, such as during reperfusion, they
take a pathophysiological role and tend to interrupt nor-
mal signalling pathways. They may directly injure cellular
compounds, especially lipid membranes [27].
The oxidative stress theory has long been considered the
primary deleterious effect of reperfusion, all the more so
when ROS scavengers were proven experimentally to pre-
vent reperfusion injury. For example, as early as 1989,
Bolli et al. [30] showed that a potent and cell-permeable
antioxidant administered as an intracoronary infusion in
a myocardial infarction model in dogs, before and during
reperfusion, resulted in a signiﬁcant improvement of con-
tractile function compared with control animals.
The energy paradox
The energy paradox hypothesis suggests that restarting
mitochondrial ATP synthesis — the aim of revascularization
— leads to a cascade of paradoxical events resulting in an
increase in cellular damage [14] (Fig. 3). By deﬁnition, this
means that the mitochondrial ATP-production machinery is
not excessively damaged by ischaemia and is able, due to the
return of substrates and oxygen, to start synthesizing ATP,
even at only a low level. In several studies, a direct blocker
of the myoﬁbrils (2,3 butane dionemonoxime-BMD) inhibited
infarct size by one half [31]. The reperfusion energy sce-
nario results in cardiomyocyte death by two mechanisms,
one leading to broken membranes, either directly and/or
due to ischaemic cytoskeleton fragility; the second result-
ing in new damage to the energy-cell factory [14,32]. The
i
c
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eason behind the latter is the opening of the mitochon-
rial permeability transition pore (mPTP) [33], a recently
iscovered mitochondrial pore, which remains closed during
schaemia and opens early during reperfusion (Fig. 4).
The ﬁrst act in the sequence of events is due directly to
he restarting of ionic pumps, which try to correct the ionic
schaemic disequilibrium [14,19—21,32]. At the end of a pro-
onged period of ischaemia, the cytosol is overloaded with
a+, Ca2+ and H+. Acidosis is corrected rapidly by the efﬂux
f H+ through the Na+/H+ exchanger and the Na+/HCO3−
ymporter located in the sarcolemma. This results in intra-
ellular Na+ overload, which in turn creates Na+ efﬂux in
xchange for Ca2+, leading in a large overload of Ca2+. Sev-
ral authors have even proposed a reverse function of the
a+/Ca2+ exchanger [19,20] and as a consequence a sup-
lementary increase of intracellular Na+ parallel to that of
a2+. Finally, if the Na+/K+ ATP-dependent channel is able to
unction again, Na+ will leave the cytosol in return for K+.
Irrespective of the precisemolecular mechanism involved
n the complex ionic features occurring at reperfusion, the
ain result is a reperfusion-linked calcium overload added
o the ischaemic calcium overload. Reperfusion with a low
alcium buffer abolishes the increase in Ca2+ uptake and
esults in an improvement in ventricular function recov-
ry [34]. Activation of the Ca2+ sarcoplasmic reticulum
TP-dependent pump, or SERCA, leads to a temporary
equestration of excess Ca2+ within this intracellular stor-
ge organelle [13,14,20,22,32,35]. If the capacity of this
rganelle is too small for the amount of Ca2+ accumulated
n the cytosol, a cycle of continuous release and reup-
ake of Ca2+ from and into the sarcoplasmic reticulum is
nitiated. These spontaneous oscillations end only if the
ajor mechanism for Ca2+ extrusion from the cytosol is sufﬁ-
iently activated (Na+/Ca2+ exchange). If not, Ca2+ promotes
yoﬁbrillar permanent contraction, or hypercontracture,
ue to rapid crossbridge cycling [32], which in turn increases
ytoskeleton fragility and membrane rupture. Such myoﬁb-
illar permanent contraction can occur even at low levels
f ATP due to a slow turnover of crossbridges. In this situ-
tion, myoﬁbrillar bridges remain in a long-lasting state of
ontraction called rigor contracture, and may also damage
he cytoskeleton and membranes [22].
The second part occurs within the mitochondrial mem-
rane. A new door between the cytoplasm and mitochondria
as been established recently [33,35,36]: mPTPs are non-
peciﬁc pores located in the inner mitochondrial membrane
nd open easily under conditions of Ca2+ overload as well
s in presence of ROS excess, ADP depletion, and inorganic
hosphate (Pi) increase [35—37]. mPTP opening results in
ncreases in mitochondrial Ca2+ and H+ as well as reactive
xygen species (ROS) synthesis. The direct role of Ca2+ over-
oad in mPTP opening is nevertheless challenged [37] and
OS may have a predominant role. When mPTP opening
asts too long, it starts to destroy the inner mitochondrial
rotection, leading to collapse of the mitochondrial mem-
rane potential and uncoupling of the respiratory chain
33,35]. Finally, ATP production, which had just restarted,n the mitochondrial membranes leading to an efﬂux of
ytochrome c. In turn, this induces the caspase cascade
nd promotes apoptosis [38]. Numerous publications con-
ider that reﬂow is the trigger of mPTP opening and that
496 J.P. Monassier
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his is a crucial event in inducing reperfusion injury. Dur-
ng ischaemia, mPTPs remain closed due to acidosis, and
hus when the pH returns to normal at the beginning of
eperfusion, the mPTPs may open.
The consequence of pH normalization, which is the trig-
er of energetic deleterious mechanisms, is called the pH
aradox [38]. Thus, recovery of the ‘‘energetic machin-
ry’’ does not always result in the recovery of the cells’
reischaemic state. On the contrary, it may cause a num-
er of unwanted effects. One might call these events the
‘energy paradox’’, meaning that resumption of ATP syn-
hesis could result in a cardiomyocyte dysfunction due to
he speed of recovery. Alternatively, mitochondria may need
ime to return to their preischaemic physiological activities,
hereas reperfusion acts as a booster, leading to an abrupt
hange in state.
To summarize, the main components of this complex
nteraction are calcium overload, ROS, and rapid normal-
zation of the intracellular pH. Adding to these is the
ashout of molecules accumulated during the ischaemic
hase, which decreases the intracellular osmotic pressure
nd consequently provokes water overload and swelling
hat may lead to rupture of the mitochondria and cell
embranes.
When cells remain viable despite experiencing severe
schaemia, they need a ‘‘warm-up’’ period to restart their
etabolic activity more slowly. Mitochondrial swelling and
ncoupling and myoﬁbrillar hypercontracture are the result
f abrupt reoxygenation.
d
a
i
treperfusion injury (adapted from Vinten-Johansen 2004 [42]).
Hypercontracture can progress from cell to cell through
ap junctions [39]. The ‘‘energetic’’ reperfusion injury
echanisms lead to a peculiar histological appearance. This
s characterized by hypercontracted sarcomeres (contrac-
ion bands) and frequent sarcolemmal ruptures that gave
ise to the term contraction band necrosis [22]. The uncon-
rolled activation of the contractile machinery depends also
n the intensity and duration of the ischaemic period. Its
ntensity is a consequence of different parameters:
endogenous catecholamine release;
arterial systolic pressure;
extent of collateral vessels.
ole of inﬂammation
n the intact organism, ischaemic myocardial injury initiates
n acute inﬂammatory response in which polymorphonu-
lear leukocytes are the major participants [39]. Evidence
ndicates that the interacting inﬂammatory reactions are
ugmented by reperfusion and can contribute to myocardial
amage [40,41]. But the direct involvement of neutrophils in
ethal reperfusion injury remains controversial. Experimen-
al inhibition or depletion of neutrophils [42], just before or
mmediately after reperfusion, has provided contradictory
ata [42,43]. Nevertheless, the participation of neutrophils
t least as co-participants and/or ampliﬁers of reperfusion
njury seems now to be recognized [42—44].
Myocardial reperfusion induces an intense accumula-
ion of neutrophils into the area of previously ischaemic
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myocardium, which can be two- to sixfold greater in the
ischaemic than in the non-ischaemic tissue [40]. Neutrophil
accumulation begins immediately after reperfusion, increas-
ing during the following 6 h [40,41]. A second phase of
increase starts 24 h later [41]. Numerous adhesion molecules
and inﬂammation mediators are expressed and/or up-
regulated and lead to the ﬁxation of leucocytes to the
endothelium and the cardiomyocytes [42,43]. Interactions
between neutrophils and endothelium are mediated by the
selectin family, particularly P-selectin expressed on the
surface of endothelial cells within the ﬁrst few minutes
of reperfusion [42]. P-selectin expression reaches a max-
imum 10—20min after reperfusion. Integrins (membrane
glycoproteins) and speciﬁcally the CD11/CD18 family are
also expressed on the leucocyte surface and result in ﬁrm
adherence to endothelial surface [42]. The immunoglob-
ulin ICAM-1, expressed on the endothelial surface and
up-regulated by proinﬂammatory mediators (ROS, IL-1,TNF-
alpha), is the endothelial counterligand of the leucocyte
surface-adhesion molecule [42]. These immunoglobulins
reach a maximum expression around 4 h after reperfusion.
Neutrophil—myocyte interactions are promoted by the
up-regulation of ICAM-1 expressed on the myocyte mem-
brane, permitting adhesion of activated leukocytes [42,44].
It must be kept in mind that leucocyte accumulation and
activation, and endothelial and myocyte adhesion start
immediately after reperfusion but last for only a few hours
[40—42]. The three pathways of the complement cascade
are activated, increasing the interaction between endothe-
lium and leucocytes [45].
The ﬁnal issue of the early but also long-lasting inﬂamma-
tory response to reperfusion can be summarized as follows:
• endothelium dysfunction with the loss of vasodilatory
properties, the release of vasoconstrictive molecules
(thromboxane A2 and endothelin), platelet activation,
and distal plugging leading to the no-reﬂow phenomenon
[42], at least in part;
• neutrophils, considered one of the major sources of ORS
[46], are involved in damage and rupture of cardiomy-
ocyte membranes.
The role of leukocytes during ischaemia and reperfusion
is the result of a complex molecular biological scenario that
has not yet been fully explained. Despite experimental evi-
dence, their role remains controversial [42,43]. Conﬂicting
results from experimental pharmacological and immunologi-
cal prevention do not rule out the role of early inﬂammation
processes in reperfusion injury; inﬂammation is probably
only one of the deleterious features of reperfusion. Inﬂam-
mation mechanisms are present not only early but also
during the next 24 h and even later.
Molecular basis of endothelial and
myocardial salvage
The concept of preconditioning, in which pretreatment with
brief episodes of ischaemia reperfusion preceding a long
period of total ischaemia resulted in a dramatic reduction
in infarct size, was introduced by Murry et al. [11] in 1986.
Their data clearly demonstrated that cell death cannot be
seen as a mere consequence of energy deﬁciency. Precondi-
p
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ioning has been reported to:
reduce infarct size;
preserve vascular endothelial function;
decrease accumulation and activation of polymorphonu-
clear neutrophils;
decrease calcium overload;
delay the restoration of neutral pH;
reduce apoptosis [38].
Postconditioning achieves the same result. Moreover, it
nhibits ROS production and decreases cellular oedema [38].
urthermore, while some authors consider that pre- and
ostconditioning have additive effects [47,48], others deny
his suggestion [49]. The precise mechanisms explaining
ostconditioning efﬁcacy have been proposed from molec-
lar biology studies. A report by Hausenloy and Yellon [50]
rovides insights, showing that it is possible to protect reper-
used myocardium by activating prosurvival kinase signalling
athways, now called the reperfusion injury salvage kinase
athway (RISK). To understand such a complex and still
volving mechanism, it appears necessary to go back from
he end effectors of the RISK pathway, to describe the RISK
ascade, and ﬁnally to identify the triggers. Whether or not
he survival mechanisms are identical for pre- and postcon-
itioning is still debated [50—52].
The end effectors of these salvage kinases are mPTP
13,33—36] and K-ATP channels [34,48,49]. When in the
pen setting (promoted by calcium overload, oxidative
tress, and ATP depletion) mPTPs lose their mitochon-
rial protective role. Thus mitochondria undergo massive
welling and become uncoupled, are unable to maintain
he pH gradient and membrane potential, and instead of
roducing ATP they start to degrade the remaining ATP
33]. A second consequence of mitochondrial swelling is
hat the architecture of the mitochondrial inner membrane
hanges, resulting in release of cytochrome c, which in turn
ctivates proapoptotic caspases [38]. The ﬁrst postcondi-
ioning mechanism appears to prevent mPTP opening and
reserves mitochondrial function [33]. Opening the mito-
hondrial K-ATP channels could be the second end effector
f postconditioning [38]. This opening provokes a partial
itochondrial membrane depolarization preventing calcium
verload. Opening of K-ATP channels might also occur in
he sarcoplasmic reticulum membrane and could decrease
ytosolic calcium overload; as a consequence, it prevents
yoﬁbrillar contracture [52]. Murata et al. [53] consider
hat K-ATP channels are already acting during ischaemia,
imiting Ca2+ overload, whereas mPTPs are involved only
uring the early reperfusion period. A ribosomal protein
p7056K) may be a third intramitochondrial RISK end effec-
or involved in an antiapoptotic role [48]. Finally, glycogen
ynthase (GSK-3B) has been proposed as the pivotal kinase
hat serves as a RISK point of convergence, receiving inputs
f these pathways and mediating both K-ATP channels and
PTPs [54].
The full mechanism of the RISK pathway is not completely
nown, but the current paradigm implicates one or more G
rotein-coupled receptors followed by a cascade of protein
inases, including protein kinase C and mitogen-activated
rotein kinases (MAPKs), which open the K-ATP channels and
lose the mPTP [50]. The MAPK pathway could be divided
nto two parallel circuits, one including phosphatidylinosol 3
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en synthase kinase-3 beta; K-ATP: potassium channels ATP-depend
ermeability transition pores; PI3K: phosphatidylinositol 3 kinase.
inase (Pi3K) and serin-threonin kinase (Akt) protein kinase B
PKB), the second, still being challenged, mitogen-activated
rotein kinase (MEK 1/2) and extracellular signal-regulated
inase (ERK 1/2). Other messengers play a part in the RISK
ascade such as NO and ROS [50,55,56].
There are many candidate trigger molecules for initiating
urvival pathways [38]: adenosine is the best known of these
riggers, such as in preconditioning. Bradykinin, which is syn-
hesized during ischaemia, and paradoxically ROS could also
nduce salvage mechanisms. Other drugs (postconditioning-
imicking drugs) such as endogenous or exogenous opioids,
icorandil, insulin, cyclosporin A, glucagon-like peptide-1,
rythropoietin, statins, cardiotrophin-1, protein kinase C,
ransforming growth factor-beta 1 might also activate this
ath and/or inhibit directly apoptosis by blocking caspases.
After preconditioning, these survival pathways have been
p-regulated and can work immediately after reperfusion. In
he case of postconditioning, they need time to start. This
ime is achieved by maintaining sufﬁcient acidosis, which
locks the opening of mPTPs [36]. At the same time, if
denosine is not drained too quickly, it has time to trigger
he RISK pathway. This is the reason why triggering the sur-
ival mechanisms is closely linked to the duration of the
nitial artery opening. This must be as short as possible and
robably not more than 1min. Nevertheless, the data we
urrently have suggest that these delays could differ from
ne animal species to another and especially for humans
38,51,52].
These active survival mechanisms can be associated with
assive ones [51] (Fig. 5). Tsang et al. [51] proposed a
ual action of postconditioning, with one being passive
not involving the RISK pathway) and the other, active one,
nducing the RISK pathway. It is, however, difﬁcult to dif-
erentiate these two mechanisms, especially because low
T
d
A
t
rase; ERK 1/2: extracellular signal-regulated kinase; GSK 3B: glyco-
MEK 1/2: mitogen-activated protein kinase; mPTP: mitochondrial
ressure reperfusion is known to activate the RISK pathway
nd attenuatesmPTP opening. Controlled and gradual reper-
usion could limit ROS burst and neutrophil accumulation. At
he same time, low-pressure reperfusion has been shown to
ecrease mPTP opening [55].
Thus, having tried to summarize the now accepted con-
ept of preventing mechanisms for lethal reperfusion injury,
t must be said not everything is fully understood. Neverthe-
ess, sufﬁcient research evidence is available to start trials
n humans.
emote preconditioning: the last good
ew?
emote preconditioning occurs when an organ is subjected
o sublethal transient ischaemia and confers protection
o another organ [57]. This phenomenon was described
ecently using mesenteric ischaemia or aortic clamping and
esulted in reduction in the size of the myocardial infarct.
n humans this technique may be achieved by intermit-
ent inﬂation of the blood pressure cuff [57,58]. Whether
emote preconditioning depends on the same survival path-
ays remains to be demonstrated, but it at least includes
rotein kinase C as does postconditioning [58].
poptosis: the secret killer?his genetically programmed form of cell death is very
ifﬁcult to detect by conventional histological methods.
poptotic cells are phagocytosed by adjacent cells without
he occurrence of inﬂammatory reactions. Their membranes
emain intact and only nuclear DNA fragmentation, which
ch to
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can be detected only using specialized techniques, is able
to prove its existence [59,60]. Irrespective of whether apop-
tosis is induced by ischaemia or by reperfusion, a general
agreement has been reached that both clinical scenarios
promote apoptosis, via the molecular mechanisms discussed
above. Apoptosis is accelerated by reperfusion, but whereas
reperfusion necrosis occurs very quickly, apoptosis when
initiated might last longer and continue to kill myocardial
cells [60]. The respective part of reperfusion injury necro-
sis and reperfusion injury apoptosis remains the subject of
debate.
Paradoxes and yet more paradoxes
Reperfusion injury in itself was considered initially as
a paradoxical reaction offsetting the optimal salvage of
myocardium [6,7,48]. However, when investigating the
mechanisms of pre- and postconditioning, other para-
doxes must also be highlighted. The need to keep a
low intracellular pH during the early phase of reperfu-
sion appears as another paradox because acidosis blocks
myocardial contraction whereas the aim of reperfusion
is to restore cardiomyocyte mechanical activity. ORS and
NO are involved in the prevention of reperfusion injury
while they have also been accused of inducing reperfu-
sion cell death. Finally the calcium and oxygen paradoxes
were ﬁrst demonstrated as early as 1978 [28] when with-
out either oxygen or calcium cardiomyocytes cannot live or
contract.
Trying to explain this cascade of paradoxes is an ideal
introduction to progress from the ‘‘bench’’ to the ‘‘cath
lab’’. Every parameter and molecule that appears to induce
paradoxical reactions is actually positively effective at
reperfusion provided that they are reintroduced at low lev-
els. Reperfusion injury is a consequence of a ‘‘to be or not to
be. . . opened’’ technique. Modifying reperfusion must there-
fore be the next goal for interventional cardiologists.
Conclusions
The reality of lethal reperfusion injury has been clearly
demonstrated. A large volume of experimental data, which
is still evolving, leads us to understand how endothe-
lium and cardiomyocytes can be protected from abrupt
reoxygenation. By progressing from the molecular basis of
ischaemia-related myocardium death to reperfusion injury
salvage pathways, it is conceivable to expect new strate-
gies to transform the interventional practice of unblocking
the culprit coronary artery in patients presenting with ST-
segment elevation myocardial infarction.
The results of basic research open up the possibility, via
pharmacological and/or mechanical options, of limiting the
ﬁnal extent of myocardial damage after a long period of
ischaemia. Prevention and treatment of lethal reperfusion
injury no longer appears as a distant dream [59].References
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